Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Pharmaceutics|May 27, 2023
A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular DiseaseAlankrita Rani, Gunther MarschePharmacology & Therapeutics|July 4, 2024
HDL-based therapeutics: A promising frontier in combating viral and bacterial infectionsAlankrita Rani, Julia T Stadler, Gunther MarscheTrends in Molecular Medicine|March 2, 2024
HDL and SARS CoV-2: emerging theragnostic implicationsAlankrita Rani, Julia T Stadler, Gunther MarscheJournal of Clinical Medicine|April 3, 2021
Exploring Obscurin and SPEG Kinase BiologyJennifer R Fleming, Alankrita Rani, Jamie Kraft, et al.Antioxidants (Basel, Switzerland)|October 27, 2022
Low HDL Cholesterol Efflux Capacity Indicates a Fatal Course of COVID-19Julia T Stadler, Harald Mangge, Alankrita Rani, et al.Journal of Lipid Research|December 31, 2025
Phospholipase A<sub>2</sub> Products Influence the Antiplatelet Functions of Synthetic High-Density LipoproteinsAntonela Rodriguez, Minzhi Yu, Jingyao Gan, et al.Journal of Lipid Research|December 13, 2022
HDL Isolated by Immunoaffinity, Ultracentrifugation, or Precipitation is Compositionally and Functionally DistinctMichael Holzer, Senka Ljubojevic-Holzer, Douglas Ricardo Souza Junior, et al.Journal of Lipid Research|August 18, 2024
Low LCAT activity is linked to acute decompensated heart failure and mortality in patients with CKDJulia T Stadler, Thomas Bärnthaler, Andrea Borenich, et al.Biomedicines|April 23, 2022
Anorexia Nervosa Is Associated with a Shift to Pro-Atherogenic Low-Density Lipoprotein SubclassesJulia T Stadler, Sonja Lackner, Sabrina Mörkl, et al.Antioxidants (Basel, Switzerland)|November 25, 2023
HDL-Related Parameters and COVID-19 Mortality: The Importance of HDL FunctionJulia T Stadler, Hansjörg Habisch, Florian Prüller, et al.Pageof 2